74 related articles for article (PubMed ID: 18833124)
1. [Efficacy of local use of recombinant interferon alpha-2 preparations in combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Katinas EB; Riabova MA; Karpishchenko SA; Totolian AA
Vestn Otorinolaringol; 2008; (4):57-61. PubMed ID: 18833124
[TBL] [Abstract][Full Text] [Related]
2. Use of interferon-alpha in recurrent respiratory papillomatosis: 20-year follow-up.
Gerein V; Rastorguev E; Gerein J; Jecker P; Pfister H
Ann Otol Rhinol Laryngol; 2005 Jun; 114(6):463-71. PubMed ID: 16042104
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report).
Nodarse-Cuní H; Iznaga-Marín N; Viera-Alvarez D; Rodríguez-Gómez H; Fernández-Fernández H; Blanco-López Y; Viada-González C; López-Saura P;
J Laryngol Otol; 2004 Sep; 118(9):681-7. PubMed ID: 15517700
[TBL] [Abstract][Full Text] [Related]
4. [Current approaches to combined treatment of recurrent respiratory papillomatosis].
Pluzhnikov MS; Riabova MA; Karpishchenko SA; Katinas EB
Vestn Otorinolaringol; 2008; (4):29-37. PubMed ID: 18837150
[No Abstract] [Full Text] [Related]
5. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.
Verra N; Jansen R; Groenewegen G; Mallo H; Kersten MJ; Bex A; Vyth-Dreese FA; Sein J; van de Kasteele W; Nooijen WJ; de Waal M; Horenblas S; de Gast GC
Br J Cancer; 2003 May; 88(9):1346-51. PubMed ID: 12778059
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of resistance to interferon in patients with laryngeal papillomatosis.
Garciá-Millián R; Santos A; Perea SE; González-Cabañas R; Valenzuela C; Araña M
Cytokines Cell Mol Ther; 1999 Jun; 5(2):79-85. PubMed ID: 10515680
[TBL] [Abstract][Full Text] [Related]
8. [Combined treatment in recurrent laryngeal papillomatosis with CO2 laser microlaryngoscopic resection and interferon alpha 2b].
Montero Mora P; Hernández Colín DD; Enríquez Palomec O; Mejía Ortega J
Rev Alerg Mex; 1996; 43(5):133-6. PubMed ID: 9005006
[TBL] [Abstract][Full Text] [Related]
9. Use of interferon-alpha in laryngeal papillomatosis: eight years of the Cuban national programme.
Deuñas L; Alcantud V; Alvarez F; Arteaga J; Benítez A; Bopuza M; Carniege L; Cartaya B; Comas C; Cotayo R; Escobar H; Fernández H; Fernández M; Fernández R; García M; Iznaga N; la O F; Márquez J; Nordet D; Pérez J; Quintero J; Redonavich A; Robeleco M; Rodríguez H; Strander H
J Laryngol Otol; 1997 Feb; 111(2):134-40. PubMed ID: 9102438
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of laryngotracheal papillomatosis with combined use of laser surgery and intralesional administration of alpha-interferon (Roferon)].
Walther EK; Herberhold C
Laryngorhinootologie; 1993 Oct; 72(10):485-91. PubMed ID: 8267824
[TBL] [Abstract][Full Text] [Related]
11. 2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.
Gerein V; Rastorguev E; Gerein J; Lodemann E; Pfister H; Draf W; Desloovere C
J Laryngol Otol; 2004 Oct; 118(10):750-6. PubMed ID: 15550179
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
Lee AS; Rosen CA
J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
[TBL] [Abstract][Full Text] [Related]
13. Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cells.
Nieda M; Terunuma H; Eiraku Y; Deng X; Nicol AJ
Exp Dermatol; 2015 Jan; 24(1):35-41. PubMed ID: 25363560
[TBL] [Abstract][Full Text] [Related]
14. Natural cytotoxicity and interferon production in patients with recurrent respiratory papillomatosis.
Naiman HB; Doyle AT; Ruben RJ; Kadish AS
Ann Otol Rhinol Laryngol; 1984; 93(5 Pt 1):483-7. PubMed ID: 6437314
[TBL] [Abstract][Full Text] [Related]
15. [Viferon treatment of recurrent respiratory papillomatosis in children].
Nurmukhametov RKh; Onufrieva EK; Soldatskiĭ IuL; Maslov IV; Tikhonenkova LP; Shchepin NV; Kol'tsov VD
Vestn Otorinolaringol; 2001; (5):47-9. PubMed ID: 11699097
[No Abstract] [Full Text] [Related]
16. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes.
Alvaro-Gracia JM; Zvaifler NJ; Firestein GS
J Clin Invest; 1990 Dec; 86(6):1790-8. PubMed ID: 2174906
[TBL] [Abstract][Full Text] [Related]
17. Failure of gamma interferon but not interleukin-10 expression in response to human papillomavirus type 11 E6 protein in respiratory papillomatosis.
DeVoti JA; Steinberg BM; Rosenthal DW; Hatam L; Vambutas A; Abramson AL; Shikowitz MJ; Bonagura VR
Clin Diagn Lab Immunol; 2004 May; 11(3):538-47. PubMed ID: 15138179
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha: a key factor in autoimmune disease?
Plskova J; Greiner K; Muckersie E; Duncan L; Forrester JV
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
[TBL] [Abstract][Full Text] [Related]
19. [Results of long-term leukocyte interferon (alpha IFN) therapy using an individually determined dose schedule in recurrent laryngeal papillomatosis].
Gerein V; Lodemann E; Bell G; von Ilberg C; Kornhuber B
Klin Padiatr; 1987; 199(3):224-9. PubMed ID: 3114545
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of patients with recurrent spontaneous miscarriage and idiopathic infertility: does the immunization-dependent Th2 cytokine overbalance really matter?
Wilczyński JR; Radwan P; Tchórzewski H; Banasik M
Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):151-60. PubMed ID: 22349103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
